Adicet Bio, Inc. Share Price
ACETAdicet Bio, Inc. Stock Performance
Open $7.41 | Prev. Close $7.38 | Circuit Range N/A |
Day Range $7.40 - $7.41 | Year Range $0.46 - $9.38 | Volume 581 |
Average Traded $7.40 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $7.41 | $7.36 | +0.00% |
10-Jun-26 | $7.41 | $7.36 | +1.31% |
08-Jun-26 | $7.29 | $7.26 | -0.82% |
05-Jun-26 | $7.86 | $7.32 | -10.61% |
04-Jun-26 | $8.03 | $8.19 | +3.79% |
03-Jun-26 | $7.82 | $7.89 | -3.19% |
02-Jun-26 | $8.32 | $8.15 | -7.49% |